Legis Daily

To amend the Federal Food, Drug, and Cosmetic Act to establish special rules to provide for continued review of human drug and device submissions during a lapse of appropriations, and for other purposes.

USA119th CongressHR-9635| House 
| Updated: 7/9/2026
Kevin Mullin

Kevin Mullin

Democratic Representative

California

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Timeline
Jul 9, 2026
Introduced in House
Jul 9, 2026
Referred to the House Committee on Energy and Commerce.
  • July 9, 2026
    Introduced in House


  • July 9, 2026
    Referred to the House Committee on Energy and Commerce.

To amend the Federal Food, Drug, and Cosmetic Act to establish special rules to provide for continued review of human drug and device submissions during a lapse of appropriations, and for other purposes.

USA119th CongressHR-9635| House 
| Updated: 7/9/2026
Timeline
Jul 9, 2026
Introduced in House
Jul 9, 2026
Referred to the House Committee on Energy and Commerce.
  • July 9, 2026
    Introduced in House


  • July 9, 2026
    Referred to the House Committee on Energy and Commerce.
Kevin Mullin

Kevin Mullin

Democratic Representative

California

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted